1.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 9090-03, NCT00858572
|
|
2.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 9090-04, NCT00964873
|
|
3.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 9090-05, NCT01039519
|
|
4.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: 10-029, NCT01111838
|
|
5.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: 10-145, NCT01273896
|
|
6.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Temporarily closed Age: 18 and over Sponsor: Other Protocol IDs: 10-333, NCT01368003
|
|
7.
|
Phase: Phase I Type: Treatment Status: Closed Age: 25 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 9090-02, NCT00687934
|